467 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
Dermaplaning removes peach fuzz and exfoliates the skin, but does the hair grow back thicker? We examine the science, the safety rules, and at-home vs in-office risks.
HydraFacials are marketed heavily for an event glow, but is the cost justified? We analyze the vortex technology, the thin clinical evidence, and the FDA Class I device…
Sunken temples can age the upper face, but vascular safety is critical. We analyze Juvéderm Voluma, Restylane Contour, off-label biostimulators, and FDA MAUDE safety…
Do collagen powders, drinks, and gummies really work for skin hydration and wrinkles? Read what meta-analyses of clinical trials show regarding dosage, marine vs. bovine…
Is hip dip filler safe? Learn about the anatomy of the lateral trochanteric depression, the off-label status of Sculptra and HA fillers, costs, and BBL safety-plane…
Why professional diagnosis is crucial before skin tag removal. Learn about dermatologist methods, costs, and the serious risks of OTC kits highlighted by the FDA.
FDA warning letters target sellers of semaglutide and retatrutide labeled 'for research use only'. Injecting these unapproved chemicals carries severe clinical and legal…
The FDA's April 2026 warning letter to a Texas med spa marks the first time a medical spa has been cited under the DSCSA. Sourcing, records, and unit-reconciliation…
While key parts of MoCRA are active, several rules remain pending, delayed, or withdrawn in 2026. An analysis of the FDA adverse-event database reveals a…
An evidence-based safety and regulatory review of unapproved fat-dissolving injections (Aqualyx, Lipo Lab, compounded PCDC) versus FDA-approved Kybella, analyzing FAERS…